Unknown

Dataset Information

0

Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation.


ABSTRACT: N6-methyladenosine (m6A) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of m6A on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activity and m6A-mRNA are dysregulated in multiple diseases including cancers, yet endogenous signaling molecules that modulate FTO activity have not been identified. Here we show that nitric oxide (NO) is a potent inhibitor of FTO demethylase activity by directly binding to the catalytic iron center, which causes global m6A hypermethylation of mRNA in cells and results in gene-specific enrichment of m6A on mRNA of NO-regulated transcripts. Both cell culture and tumor xenograft models demonstrated that endogenous NO synthesis can regulate m6A-mRNA levels and transcriptional changes of m6A-associated genes. These results build a direct link between NO and m6A-mRNA regulation and reveal a novel signaling mechanism of NO as an endogenous regulator of the epitranscriptome.

SUBMITTER: Kuschman HP 

PROVIDER: S-EPMC10623363 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nitric oxide inhibits FTO demethylase activity to regulate N<sup>6</sup>-methyladenosine mRNA methylation.

Kuschman Hannah Petraitis HP   Palczewski Marianne B MB   Hoffman Brian B   Menhart Mary M   Wang Xiaowei X   Glynn Sharon S   Islam Abul B M M K ABMMK   Benevolenskaya Elizaveta V EV   Thomas Douglas D DD  

Redox biology 20231014


N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of m<sup>6</sup>A on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activity and m<sup>6</sup>A-mRNA are dysregulated in multiple diseases including cancers, yet endogenous signaling molecules that modulate FTO activity have not been identified. He  ...[more]

Similar Datasets

2024-06-30 | GSE236272 | GEO
2024-06-30 | GSE236271 | GEO
2024-06-30 | GSE236270 | GEO
2024-06-30 | GSE236269 | GEO
| PRJNA989601 | ENA
| PRJNA989607 | ENA
| PRJNA989605 | ENA
| PRJNA989609 | ENA
| S-EPMC8994758 | biostudies-literature
| S-EPMC8453432 | biostudies-literature